254 related articles for article (PubMed ID: 23846739)
1. The multiple faces of CCL13 in immunity and inflammation.
Mendez-Enriquez E; García-Zepeda EA
Inflammopharmacology; 2013 Dec; 21(6):397-406. PubMed ID: 23846739
[TBL] [Abstract][Full Text] [Related]
2. A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma.
Méndez-Enríquez E; Medina-Tamayo J; Soldevila G; Fortoul TI; Anton B; Flores-Romo L; García-Zepeda EA
Int Immunopharmacol; 2014 May; 20(1):1-11. PubMed ID: 24560857
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.
Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP
J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641
[TBL] [Abstract][Full Text] [Related]
4. CCR1 and CCR2 antagonists.
Zimmermann HW; Sterzer V; Sahin H
Curr Top Med Chem; 2014; 14(13):1539-52. PubMed ID: 25159163
[TBL] [Abstract][Full Text] [Related]
5. Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling.
Heinemann A; Hartnell A; Stubbs VE; Murakami K; Soler D; LaRosa G; Askenase PW; Williams TJ; Sabroe I
J Immunol; 2000 Dec; 165(12):7224-33. PubMed ID: 11120855
[TBL] [Abstract][Full Text] [Related]
6. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
[TBL] [Abstract][Full Text] [Related]
7. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor antagonists: Part 1.
Pease JE; Horuk R
Expert Opin Ther Pat; 2009 Jan; 19(1):39-58. PubMed ID: 19441897
[TBL] [Abstract][Full Text] [Related]
10. Chemokine Receptor Redundancy and Specificity Are Context Dependent.
Dyer DP; Medina-Ruiz L; Bartolini R; Schuette F; Hughes CE; Pallas K; Vidler F; Macleod MKL; Kelly CJ; Lee KM; Hansell CAH; Graham GJ
Immunity; 2019 Feb; 50(2):378-389.e5. PubMed ID: 30784579
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of Galpha16 in CC chemokine-induced stimulation of phospholipase Cbeta, ERK, and chemotaxis.
Tian Y; Lee MM; Yung LY; Allen RA; Slocombe PM; Twomey BM; Wong YH
Cell Signal; 2008 Jun; 20(6):1179-89. PubMed ID: 18406577
[TBL] [Abstract][Full Text] [Related]
12. Eotaxin and monocyte chemotactic protein-3 use different modes of action.
Chung IY; Kim YH; Choi MK; Noh YJ; Park CS; Kwon DY; Lee DY; Lee YS; Chang HS; Kim KS
Biochem Biophys Res Commun; 2004 Feb; 314(2):646-53. PubMed ID: 14733956
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide: An endogenous regulator of the immune system.
Dilek N; Papapetropoulos A; Toliver-Kinsky T; Szabo C
Pharmacol Res; 2020 Nov; 161():105119. PubMed ID: 32781284
[TBL] [Abstract][Full Text] [Related]
15. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3.
Garcia-Zepeda EA; Combadiere C; Rothenberg ME; Sarafi MN; Lavigne F; Hamid Q; Murphy PM; Luster AD
J Immunol; 1996 Dec; 157(12):5613-26. PubMed ID: 8955214
[TBL] [Abstract][Full Text] [Related]
16. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B.
Combadiere C; Ahuja SK; Van Damme J; Tiffany HL; Gao JL; Murphy PM
J Biol Chem; 1995 Dec; 270(50):29671-5. PubMed ID: 8530354
[TBL] [Abstract][Full Text] [Related]
18. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis.
Iwamoto T; Okamoto H; Iikuni N; Takeuchi M; Toyama Y; Tomatsu T; Kamatani N; Momohara S
Rheumatology (Oxford); 2006 Apr; 45(4):421-4. PubMed ID: 16303818
[TBL] [Abstract][Full Text] [Related]
20. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces.
Vanbervliet B; Homey B; Durand I; Massacrier C; Aït-Yahia S; de Bouteiller O; Vicari A; Caux C
Eur J Immunol; 2002 Jan; 32(1):231-42. PubMed ID: 11782014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
